In the media 26 Jun 2024 Framework to help curb visceral leishmaniasis in East Africa Health Policy Watch
In the media 25 Jun 2024 Consider This: Dengue vaccine (part 3) — Pandemic lessons: Prevent vaccine inequity Astro Awani
Press releases 24 Jun 2024 Paediatric malaria treatment developed in Brazil by not-for-profit organizations distributed to Indigenous children in the Amazon region
In the media 22 Jun 2024 What role does capacity development play in transforming health research? Health Policy Watch
Press releases 12 Jun 2024 New framework for visceral leishmaniasis elimination launched for Eastern Africa
Scientific articles 31 May 2024 Demystifying in vivo bioluminescence imaging of a Chagas disease mouse model for drug efficacy studies Journal of Visualized Experiments
Stories 23 May 2024 Defying the odds: One doctor’s remarkable journey to helping patients with kala-azar
Press releases 5 Feb 2019 Wellcome commits £10 million to DNDi to develop new generation of oral drugs to treat leishmaniasis
Press releases 30 Jan 2019 Fexinidazole, the first all-oral treatment for sleeping sickness, approved in Democratic Republic of Congo
Press releases 29 Jan 2019 MMV and DNDi make 400 compounds available to stimulate research into new drugs for pandemic diseases
Press releases 23 Jan 2019 Drugs for Neglected Diseases initiative and The BMJ launch a special collection on neglected diseases and innovation in South Asia
Press releases 17 Jan 2019 Combination therapy found to be more effective in treating patients with leishmaniasis and HIV
Press releases 16 Nov 2018 European Medicines Agency recommends fexinidazole, the first all-oral treatment for sleeping sickness
Press releases 12 Sep 2018 New hope for PKDL patients in Africa as clinical trial aims to make treatment safer and easier
Press releases 5 Sep 2018 DNDi and Fiocruz launch project to expand access to diagnosis and treatment for Chagas disease in Brazil
Press releases 23 Jul 2018 FIND and DNDi team up to support Malaysian MOH efforts to simplify and decentralize hepatitis C screening & treatment
Press releases 14 Apr 2018 DNDi agreement with Colombia Ministry of Health and Social Welfare to guarantee access to comprehensive care for Chagas patients
Press releases 13 Apr 2018 Clinical trial to find new treatment for visceral leishmaniasis begins in eastern Africa
Press releases 5 Apr 2018 Takeda Pharmaceutical and DNDi collaborate to progress a potential new drug for visceral leishmaniasis through the R&D pipeline
Press releases 27 Mar 2018 DNDi, GlaxoSmithKline, and University of Dundee to identify drug candidates to treat leishmaniasis and Chagas disease
Press releases 5 Mar 2018 Pharmaceutical companies and non-profits team up to provide affordable hepatitis C treatment in Latin America